Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIR-2218 Alone or in Combination With Pegylated Interferon Alpha-2a in Chronic Hepatitis B
NCT04412863Phase 2Completed
- Sponsor
- Vir Biotechnology
- Start
- Jul 2020
- Primary completion
- Mar 2024
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 6
01
Overview
A Phase 2 trial of elebsiran in Chronic Hepatitis B (CHB), sponsored by Vir Biotechnology. Started Jul 2020; status: completed.
02
Drugs
elebsiran
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04412863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04412863.